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ABSTRACT
There is accumulating evidence of a mutual relationship between multiple sclerosis and structural epilepsy. 
Comorbidity of these severe neurological disorders is reported in numerous recent publications in the avail-
able foreign literature. Modern diagnostic tools include comprehensive neurological examinations as well 
as computed tomography, electroencephalography and 18FFDG positron emission tomography. In this paper 
we report the case of a female patient with multiple sclerosis and structural epilepsy who was admitted to 
the clinic due to weakness of left limbs, difficulty in walking, and blurred vision in the left eye. The neuro-
logical examination showed small horizontal nystagmus, left-sided hemianopia, quadrihyperreflexia, non-
sustained clonus of both feet, left-sided latent hemiparesis, paresthesia in the left limbs. Electroencephalog-
raphy (EEG) revealed paroxysmal activity on the left side, MRI indicated evidence of cerebrospinal MS with 
activity . 18FFDG PET scans were normal. Based on the literature data and our own case report we could draw 
the conclusion that as epileptic seizures in MS patients may occur due to inflammatory plaques of demyelin-
ation it could be suggested that there exists a correlation between MS and structural epilepsy.
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INTRODUCTION
Evidence exists that some symptoms of mul-
tiple sclerosis (MS) which are due to plaques of de-
myelination in the affected brain areas may be simi-
lar to those of structural epilepsy. Recently, essential 
contemporary viewpoints in the field of epileptic sei-
zures in patients with MS have been summarized (1).
It has been suggested that cortical and subcor-
tical demyelination and inflammation could explain 
the increased frequency of seizures in MS (12).
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lobe, in insular cortex and in cingulate gyrus of these 
patients than in 23 disease duration-matched MS pa-
tients without epilepsy (p<0.05 for all comparisons).
In a three-year longitudinal study, the com-
parison between 32 relapsing-remitting MS patients 
with epilepsy and 60 matched patients without epi-
lepsy reveals that at baseline, cortical lesions are ob-
served in 84.38% of the cases in the first group and 
in 43.33% of the cases in the second group (p<0.001) 
(4). The number and total volume of these lesions are 
higher (10.2±8.9 versus 4.5±2.4; p<0.001 and 2.0±1.3 
The 18FFDG-PET/CT co-registration for local-
ization diagnosis of epileptogenic brain lesions in 21 
patients with structural epilepsy reveals a larger zone 
of hypometabolism than the anatomical image of the 
corresponding brain lesion in 11 cases (2). Comput-
ed tomography (CT) shows a larger epileptogenic re-
gion in four cases.
MS patients with seizures have a significantly 
higher number of cortical and juxtacortical lesions 
on T2-weighted/fluid attenuation inversion recovery 
magnetic resonance imaging than MS patients with-
out epilepsy (15).
CASE REPORT
A 24-year-old woman with MS was hospital-
ized in January, 2014 in the First Multiprofile Clin-
ic of Neurology at St. Marina University Hospital of 
Varna, on the occasion of weakness of left limbs, dif-
ficulty in walking, and blurred vision in the left eye. 
She reported that she had a ‘twist’ on the left eye and 
double vision about four to five years before. Brain 
magnetic resonance imaging (MRI) in 2008 demon-
strated optic neuritis. In 2011, she complained of vi-
sion loss in the right eye. In July, 2013, she report-
ed numbness in the left limbs and blurred vision in 
the left eye. MRI indicated evidence of cerebrospinal 
MS with activity (Fig.1). The findings of 18FFDG PET 
were normal (Fig.2). From November, 2013 to Janu-
ary, 2014, she experienced two seizures with incon-
tinence during sleep. In November, 2013, electroen-
cephalography (EEG) revealed paroxysmal activity 
on the left side. Small horizontal nystagmus, left-sid-
ed hemianopia, quadrihyperreflexia, non-sustained 
clonus of both feet, left-sided latent hemiparesis, par-
esthesia in the left limbs were found on neurologi-
cal examination. Laboratory examinations remained 
within reference limits. In January, 2014, EEG identi-
fied diffusely scattered sharp and theta waves.
DISCUSSION
The investigation of 23 relapsing remitting MS 
patients with epileptic seizures by advanced multi-
modal 3T MRI reveals that the regions most affect-
ed by grey matter lesions are the hippocampus (in 
14.2%), the lateral temporal lobe (in 13.5%), the cin-
gulate (in 100%) and the insula (in 8.4% of the cases) 
(5). There are more alterations of diffusion metrics 
and cortical thinning in several regions of temporal 
Fig. 1. MRI findings in line with MS
Fig. 2. Normal FDG-PET/CT
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versus 0.7±0.8 cm3; p<0.001, respectively) among 
the MS patients with epilepsy. Global cortical thick-
ness is, however, lower in this group (2.12±0.19 ver-
sus 2.35±0.14 mm; p<0.001). After three years, these 
patients present with a higher accumulation of new 
cortical lesions (3.4±3.2 versus 1.2±1.1; p<0.001) and 
with a faster reduction of the grey matter fraction 
(p=0.022). 
The systematic analysis of 32 population-
based studies searched in PubMed, EMBASE, Web of 
Knowledge, and Scopus databases, as well as in con-
ference proceedings reference lists indicates that the 
incidence rate of seizure disorders among MS pa-
tients is 2.28% while the prevalence rate is 3.09% (14).
The analysis of two datasets of linked statistical 
hospital admission records reveals that the relative 
risk for admission for epilepsy following an admis-
sion for MS is significantly high - at 4.1 in the Oxford 
Record Linkage Study area (1963-1998) and at 3.3 - 
in all England (1999-2011) (3). The relative risk for a 
first recorded admission for epilepsy ≥10 years after 
the first recorded admission for MS is 4.7 and 3.9, re-
spectively. The relative risk for the converse-MS fol-
lowing hospitalization for epilepsy is 2.5 and 1.9, re-
spectively. One possible explanation is that a MS le-
sion acts as a focus of an epileptic seizure.
In a retrospective population-based study be-
tween April, 2003 and July, 2010 in Iran, there is 
epilepsy in 81 out of 3522 MS patients (in 2.29% 
of the cases) (11). Epilepsy has occurred within a 
mean duration of 5.6±5.4 years after MS in 64 cas-
es (in 79.01%), a at MS onset as the presenting symp-
tom in five cases (in 6.17%) and by a mean duration 
of 4.3±4.3 years prior to MS onset in 12 patients (in 
14.81% of the cases). The results from the same study 
display that early-onset MS defined as the first pre-
sentation of symptoms before the age of 16 years is 
diagnosed in 117 patients, 19 males and 98 females, 
with a mean age at onset of 14.2±2.0 years (range: 
7-16 years) (10). Among them, ten patients have ex-
perienced at least two epileptic seizures, providing a 
crude prevalence rate of 8.55%. This value is signif-
icantly greater (p<0.001) than that of the non-early-
onset MS cohort.
The evaluation of 255 patients with MS from 
the United Kingdom MS Tissue Bank demonstrates 
seizures in 37 cases, i. e. 14.51% lifetime incidence 
rate (17). In them, death and wheelchair use occur 
earlier and in 59% of the cases, seizures develop 15 
years after the disease onset. Epilepsy is associated 
with type 1 grey matter lesions which underlie a loss 
of inhibitory interneurons in cortical layers IV and 
VI as well as with reduced cortical thickness in the 
middle temporal gyrus.
The investigation of MS patients living in the 
County of Vestfold, Norway, during the period be-
tween 1963 and 2003 demonstrates that the portion 
of the cases with epileptic seizures increases from 
2.9% in 1963 up to 7.4% in 2003 (13).
The retrospective review of the records of MS 
patients between 2009 and 2012 at Pontificia Uni-
versidad Católica of Chile’s Multiple Sclerosis Cen-
ter shows that ten out of 310 patients (3.23% of the 
cases) have epilepsy (20). These patients are younger 
(aged 32 versus 40 years; p=0.04) and have an earli-
er onset of MS symptoms (at the age of 25 versus 32 
years; p=0.02) when compared to the patients with-
out epilepsy. In four patients, seizures are the first MS 
symptom. The most frequent seizure type is partial 
secondary generalized (in six patients). MRI shows 
cortical lesions in all the cases. Along with the pro-
gressive brain atrophy, these lesions could, probably, 
be the pathophysiological mechanism underlying the 
association between epilepsy and MS.
Among 2300 patients with definite MS, there 
are 36 with epileptic seizures while among 146 pe-
diatric cases, ≤16 years of age, there are eight with 
seizures (9). Prevalence rate of epileptic seizures is 
1.5% in definite MS patients, 1.3% in adult-onset and 
5.5% in pediatric MS patients. Mean annual relapse 
rate (p≤0.001), mean expanded disability status scale 
score (p=0.04) and the ratio of patients with pedi-
atric onset (p=0.01) are higher in MS patients with 
seizures.
Among 63 MS Japanese patients, there are four 
cases with epileptic seizures (6.35%) at a mean age of 
32.5 years (16). MS onset age of patients with seizures 
is significantly younger than that without seizures by 
13.1 years. The patients show brain lesions on MRI.
Eight out of 93 Chinese relapsing-remitting MS 
patients (8.60% of the cases) have epileptic seizures 
(7). The seizure type is focal onset in all of them as 
six patients have secondarily generalized seizures. 
On EEG, only one patient has focal epileptiform dis-
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charges. The frequency of seizures is significant-
ly higher in patients with recurrent seizures than in 
those with acute-MS-related ones in whom there are 
diffuse or extensive lesions.
The role of the comprehensive clinical, MRI 
and 18FFDG PET examinations for the diagnosis of a 
rare case of glioblastoma multiforme, multiple scle-
rosis and epilepsy was emphasized (8). 
The analysis of the authors’ own experience and 
of 25 scientific papers demonstrates that 1.95% of MS 
patients experience seizures at any time during life 
(19). There are three groups of patients experiencing 
seizures before MS diagnosis: i) in 25 or 7.3% of the 
cases, seizure is the initial presentation of MS; ii) in 
27 or 7.9% of the cases, seizures appear with other 
signs and symptoms of MS, and iii) in 68 or 20% of 
the cases, seizures occur years or an unknown peri-
od of time before MS onset. The higher prevalence 
rate of seizures among MS patients than that in the 
general population indicates a relationship between 
these diseases.
The median age at occurrence of the first ep-
ileptic seizure in 67 MS patients in whom epileptic 
seizure could be explained by MS only is 33 years 
(6). Epilepsy is the initial clinical MS manifestation 
in seven patients. Some 62 patients (92.54%) pres-
ent with only one or a few seizures, and 18 patients 
(26.87% of the cases) present with at least one epi-
sode of status epilepticus that is fatal in two patients. 
There is a positive association between the pres-
ence of epilepsy in MS patients and the abnormalities 
of brainstem auditory and upper short latency so-
matosensory evoked potentials (18). Thus, brainstem 
lesions may be the cause of epileptogenicity in MS.
Based on the literature data and our own case 
report we could draw the conclusion that as epileptic 
seizures in MS patients may occur due to inflamma-
tory plaques of demyelination it could be suggested 
that there exists a correlation between MS and struc-
tural epilepsy.
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